Exacis Biotherapeutics Focuses on immuno-oncology Creates innovative, engineered T and NK cells from induced pluripotent stem cells (iPSC) In-licenses mRNA technologies developed by Factor Bioscience […]
Boston, May 11, 2020 – The Communications Strategy Group Inc. (CSG), announced today that it has formed a partnership agreement with UK-based Charles Consultants, a […]
March 26, 2020 – Marblehead, MA, USA – The Communications Strategy Group Inc., (CSG) a Boston-area based international communications and business development consultancy, announced today […]